Recombinant Mouse Mesothelin protein (rFc Tag)
Species
Mouse
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg2864
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Mouse Mesothelin protein Asp298-Ser600 (Accession# Q61468) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 56047 |
Accession | Q61468 |
PredictedSize | 60.2 kDa |
SDS-PAGE | 62-80 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Mesothelin (MSLN) is a cell-surface glycoprotein with normal expression restricted to mesothelial cells lining the pleura, peritoneum, and pericardium. MSLN is highly expressed in mesothelioma, lung, pancreas, breast, ovarian, and other cancers as a cell-surface antigen implicated in tumor invasion. MSLN is considered to be involved in several mechanisms of cancer pathogenesis. MSLN is emerging as an attractive target for cancer immunotherapy, considering its low expression on normal mesothelial cells and high expression in a broad spectrum of solid tumors.
References:
1.Morello A. et al. (2016) Cancer Discov. 6(2):133-146. 2.Klampatsa A. et al. (2021) Expert Opin Biol Ther. 21(4):473-486. 3.Cao B. et al. (2021) Int J Biol Sci. 17(14):3850-3861.